HomeARQT • NASDAQ
add
Arcutis Biotherapeutics Inc
Previous close
$24.76
Day range
$23.49 - $24.25
Year range
$11.86 - $31.77
Market cap
2.96B USD
Avg Volume
1.35M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 129.50M | 81.48% |
Operating expense | 99.43M | 37.93% |
Net income | 17.40M | 261.24% |
Net profit margin | 13.43 | 188.82% |
Earnings per share | 0.13 | 244.44% |
EBITDA | 18.95M | 358.92% |
Effective tax rate | 2.63% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 220.98M | -3.06% |
Total assets | 432.97M | 24.10% |
Total liabilities | 243.49M | 27.25% |
Total equity | 189.48M | — |
Shares outstanding | 124.03M | — |
Price to book | 16.08 | — |
Return on assets | 11.44% | — |
Return on capital | 15.97% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 17.40M | 261.24% |
Cash from operations | 26.18M | 3,600.67% |
Cash from investing | -34.18M | -198.00% |
Cash from financing | 3.72M | 103.82% |
Net change in cash | -4.21M | 93.37% |
Free cash flow | 18.21M | 294.97% |
About
Founded
2016
Headquarters
Website
Employees
354
